- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Inogen Inc (INGN)
Inogen Inc stock price live, this page displays NASDAQ INGN stock exchange data. View the INGN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Inogen Inc real time stock price chart below.
What Is the Inogen Inc Stock Price Today?
The Inogen Inc stock price today is 6.45.
What Is the Stock Symbol for Inogen Inc?
The stock symbol for Inogen Inc is "INGN."
What Stock Exchange Does Inogen Inc Trade On?
Inogen Inc is listed and trades on the NASDAQ stock exchange.
Is Inogen Inc a Good Stock to Buy?
Determining whether Inogen Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the INGN quote. (ISIN: US45780L1044)
What Is the Inogen Inc Stock Price Today?
The Inogen Inc stock price today is 6.45.
What Is the Stock Symbol for Inogen Inc?
The stock symbol for Inogen Inc is "INGN."
What Stock Exchange Does Inogen Inc Trade On?
Inogen Inc is listed and trades on the NASDAQ stock exchange.
Is Inogen Inc a Good Stock to Buy?
Determining whether Inogen Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the INGN quote. (ISIN: US45780L1044)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.06
6.53
52 wk Range
5.34
9.13
INGN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.066.53
52 wk Range
5.349.13
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
INGN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
13.00
Upside
+101.55%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low revenue valuation multiple
- Inogen authorizes $30 million stock buyback program
- Investing.com
- Form DEF 14A Inogen Inc For: 19 February
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
Inogen Inc Earnings Call Summary for Q3/2025
- Inogen Q3 2025 reported EPS of -$0.20 (beating -$0.21 forecast) with revenue of $92.39M (0.94% below expectations), while maintaining positive adjusted EBITDA for the third consecutive quarter.
- Despite revenue miss, stock rose 2.23% to $8.24 in premarket trading, with international B2B revenue growing 18.8% YoY while direct-to-consumer sales declined 17.9% YoY.
- Company maintained full-year revenue guidance of $354-357M (6% YoY growth) and raised adjusted EBITDA guidance to $2M, with Q4 revenue expected between $87-90M.
- Inogen launched the Voxy 5 stationary oxygen concentrator, with sales impact expected in 2026, while continuing to advance reimbursement efforts for Symbiox product.
- CEO Kevin Smith emphasized international expansion as a 'key pillar' of long-term growth strategy, despite challenges from declining direct-to-consumer sales and gross margin pressure.
Last Updated: 2025-11-05, 09:22 a/m
Read Full TranscriptCompare INGN to Peers and Sector
Metrics to compare | INGN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipINGNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.7x | −11.0x | −0.5x | |
PEG Ratio | −0.18 | −0.13 | 0.00 | |
Price/Book | 0.9x | 5.0x | 2.6x | |
Price / LTM Sales | 0.5x | 5.0x | 3.1x | |
Upside (Analyst Target) | 101.6% | 79.0% | 58.4% | |
Fair Value Upside | Unlock | −0.9% | 9.3% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 13.00
(+101.55% Upside)
Earnings
Latest Release
Feb 24, 2026
EPS / Forecast
-0.26 / -0.33
Revenue / Forecast
81.7M / 88.6M
People Also Watch
FAQ
What Is the Inogen Inc (INGN) Stock Price Today?
The Inogen Inc stock price today is 6.45 USD.
What Stock Exchange Does Inogen Inc Trade On?
Inogen Inc is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Inogen Inc?
The stock symbol for Inogen Inc is "INGN."
What Is the Inogen Inc Market Cap?
As of today, Inogen Inc market cap is 175.65M USD.
What Is Inogen Inc's Earnings Per Share (TTM)?
The Inogen Inc EPS (TTM) is -0.86.
When Is the Next Inogen Inc Earnings Date?
Inogen Inc will release its next earnings report on Apr 30, 2026.
From a Technical Analysis Perspective, Is INGN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Inogen Inc Stock Split?
Inogen Inc has split 0 times.
How Many Employees Does Inogen Inc Have?
Inogen Inc has 753 employees.
What is the current trading status of Inogen Inc (INGN)?
As of Mar 24, 2026, Inogen Inc (INGN) is trading at a price of 6.45 USD, with a previous close of 6.45 USD. The stock has fluctuated within a day range of 6.06 USD to 6.53 USD, while its 52-week range spans from 5.34 USD to 9.13 USD.
What Is Inogen Inc (INGN) Price Target According to Analysts?
The average 12-month price target for Inogen Inc is 13.00 USD, with a high estimate of 14 USD and a low estimate of 12 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +101.55% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.